Your browser doesn't support javascript.
loading
Angiotensin-converting enzyme inhibitors for ovarian cancer? - a new adjuvant option or a silent trap.
Regulska, Katarzyna; Michalak, Marcin; Kolenda, Tomasz; Kozlowska-Maslon, Joanna; Guglas, Kacper; Stanisz, Beata.
Affiliation
  • Regulska K; Pharmacy, Greater Poland Cancer Centre, Poznan, Poland.
  • Michalak M; Department of Clinical Pharmacy and Biopharmacy, Poznan University of Medical Sciences, Poznan, Poland, Collegium Pharmaceuticum, Poznan, Poland.
  • Kolenda T; Research and Implementation Unit, Greater Poland Cancer Center, Poznan, Poland.
  • Kozlowska-Maslon J; Surgical, Oncological and Endoscopic Gynaecology Department, Greater Poland Cancer Center, Poznan, Poland.
  • Guglas K; Research and Implementation Unit, Greater Poland Cancer Center, Poznan, Poland.
  • Stanisz B; Laboratory of Cancer Genetics, Greater Poland Cancer Center, Poznan, Poland.
Rep Pract Oncol Radiother ; 28(4): 551-564, 2023.
Article in En | MEDLINE | ID: mdl-37795232
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Observational_studies Language: En Journal: Rep Pract Oncol Radiother Year: 2023 Document type: Article Affiliation country:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Observational_studies Language: En Journal: Rep Pract Oncol Radiother Year: 2023 Document type: Article Affiliation country: